Prognostic value of cribriform size, percentage, and intraductal carcinoma in Gleason score 7 prostate cancer with cribriform Gleason pattern 4

筛状 淋巴血管侵犯 医学 前列腺癌 前列腺切除术 生化复发 病态的 病理 癌症 泌尿科 内科学 转移
作者
Zhengshan Chen,Huy P. Pham,Andre Luis Abreu,Mahul B. Amin,Andy Sherrod,Guang‐Qian Xiao,Manju Aron
出处
期刊:Human Pathology [Elsevier BV]
卷期号:118: 18-29 被引量:17
标识
DOI:10.1016/j.humpath.2021.09.005
摘要

Cribriform Gleason pattern 4 (CGP4) is an indicator of poor prognosis in Gleason Score 7 prostate cancer; however, the significance of the size and percentage of this pattern and the presence of concomitant intraductal carcinoma (IDC) in these patients is unclear. To study the significance of these parameters in radical prostatectomy specimens, 165 cases with CGP4 were identified and reviewed (2017-2019). The size and percentage cribriform pattern and presence of IDC were noted and correlated with adverse pathological features and biochemical recurrence (BCR)-free survival. On review, 156 cases had CGP4 (Grade Group 2: 87 and Grade Group 3: 69). Large cribriform pattern and cribriform percentage of >20% showed significant association with extraprostatic extension, surgical margin positivity, and presence of IDC, whereas the presence of IDC was associated with all the analyzed adverse pathological features. BCR was seen in 22 of 111 (20%) patients after a median follow-up of 11 months, and of these, 21 had large cribriform pattern. On univariate analysis, all parameters had significant predictive values for BCR-free survival except for tertiary Gleason pattern 5. On multivariate analysis, while >20% cribriform pattern was trending to be an independent predictor, only lymphovascular invasion was statistically significant. Large cribriform pattern, >20% cribriform, and presence of IDC are additional pathologic parameters of potential value in identifying patients with high risk for early BCR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
yiyao完成签到,获得积分10
刚刚
1秒前
Lybb完成签到,获得积分10
1秒前
甜乎贝贝发布了新的文献求助20
1秒前
共享精神应助玉婷采纳,获得10
2秒前
香蕉觅云应助小宇仔采纳,获得10
2秒前
adad发布了新的文献求助10
2秒前
共享精神应助核桃采纳,获得10
3秒前
wanci应助核桃采纳,获得10
3秒前
chlift发布了新的文献求助10
3秒前
lgq12697应助核桃采纳,获得10
3秒前
852应助核桃采纳,获得10
3秒前
李健应助核桃采纳,获得30
3秒前
顾矜应助核桃采纳,获得10
3秒前
天天快乐应助核桃采纳,获得10
3秒前
香蕉觅云应助核桃采纳,获得10
3秒前
李健应助核桃采纳,获得10
3秒前
爆米花应助核桃采纳,获得10
3秒前
无花果应助太空人采纳,获得30
4秒前
共享精神应助流泪猫猫头采纳,获得10
4秒前
4秒前
邓佳鑫Alan应助苹果不平采纳,获得10
4秒前
curtainai完成签到,获得积分10
4秒前
5秒前
5秒前
苗条的麦片完成签到 ,获得积分10
5秒前
5秒前
满意的聋五完成签到,获得积分10
6秒前
6秒前
Ava应助墨色采纳,获得10
6秒前
舍曲林完成签到,获得积分10
6秒前
坤坤完成签到,获得积分10
7秒前
bkagyin应助苏苏采纳,获得10
7秒前
打打应助Cindy采纳,获得10
7秒前
西柚发布了新的文献求助10
7秒前
8秒前
MZG完成签到,获得积分10
9秒前
华仔应助jiangyi采纳,获得20
9秒前
苗条的麦片关注了科研通微信公众号
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
Thomas Hobbes' Mechanical Conception of Nature 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5095428
求助须知:如何正确求助?哪些是违规求助? 4308538
关于积分的说明 13424622
捐赠科研通 4135366
什么是DOI,文献DOI怎么找? 2265484
邀请新用户注册赠送积分活动 1268868
关于科研通互助平台的介绍 1204869